Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) Director Scott Saunders sold 203 shares of the company’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the transaction, the director owned 400 shares of the company’s stock, valued at $85,700. This trade represents a 33.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Nutex Health Stock Performance
Nutex Health stock opened at $208.79 on Friday. Nutex Health Inc. has a 12-month low of $83.99 and a 12-month high of $224.28. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of 8.20 and a beta of 0.28. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The firm’s fifty day moving average price is $179.58 and its 200 day moving average price is $143.77.
Nutex Health (NASDAQ:NUTX – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million during the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. On average, research analysts forecast that Nutex Health Inc. will post 27.58 EPS for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Report on NUTX
Hedge Funds Weigh In On Nutex Health
Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Nutex Health during the second quarter valued at $69,612,000. Winmill & CO. Inc. acquired a new position in shares of Nutex Health in the 2nd quarter valued at about $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health during the 2nd quarter valued at about $7,720,000. Pacer Advisors Inc. grew its position in shares of Nutex Health by 4.3% during the 4th quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock valued at $5,480,000 after buying an additional 1,359 shares during the last quarter. Finally, SG Americas Securities LLC raised its stake in Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after acquiring an additional 29,449 shares during the period. 5.32% of the stock is currently owned by institutional investors.
Nutex Health Company Profile
Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.
Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.
Featured Articles
- Five stocks we like better than Nutex Health
- MarketBeat Week in Review – 09/14 – 09/18
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
